- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-mer
- Ligands
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 12 x 6OU: [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate(Non-covalent)
6OU.4: 12 residues within 4Å:- Chain A: F.953, G.954, M.957, L.994, F.997, R.1004, V.1007, R.1008, L.1010, F.1011, L.1345, I.1433
15 PLIP interactions:15 interactions with chain A- Hydrophobic interactions: A:F.953, A:F.953, A:L.994, A:F.997, A:F.997, A:V.1007, A:L.1010, A:F.1011, A:F.1011, A:L.1345, A:L.1345, A:I.1433, A:I.1433
- Hydrogen bonds: A:G.954
- Salt bridges: A:R.1008
6OU.5: 13 residues within 4Å:- Chain A: L.1025, M.1028, N.1100, G.1102, N.1103, F.1109, Y.1420, A.1421, M.1425, C.1428, S.1429, V.1432
- Ligands: 6OU.13
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:L.1025, A:F.1109, A:F.1109, A:A.1421, A:V.1432
- Hydrogen bonds: A:N.1100
6OU.6: 16 residues within 4Å:- Chain A: F.307, D.880, L.881, L.884, I.901, M.904, I.996, V.1000, Q.1002, M.1332, Y.1333, F.1336, F.1337, I.1339, F.1343, L.1344
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:F.307, A:F.307, A:F.307, A:L.881, A:I.901, A:I.996, A:V.1000, A:V.1000, A:Y.1333, A:F.1336, A:F.1336, A:F.1337, A:F.1337, A:I.1339, A:F.1343, A:L.1344
- Hydrogen bonds: A:D.880, A:D.880, A:Q.1002
6OU.7: 11 residues within 4Å:- Chain A: F.154, Y.157, F.158, G.503, K.504, G.507, S.508, V.511, F.512, S.515
- Ligands: 6OU.9
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.154, A:F.154, A:F.158, A:V.511, A:V.511
6OU.8: 12 residues within 4Å:- Chain A: R.295, Y.299, I.303, M.1342, F.1343, L.1346, S.1374, G.1376, K.1377, I.1379, T.1380, F.1383
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:I.303, A:M.1342, A:F.1343, A:L.1346, A:K.1377, A:I.1379, A:T.1380
- Hydrogen bonds: A:S.1374, A:K.1377
- Salt bridges: A:K.1377
6OU.9: 10 residues within 4Å:- Chain A: D.105, R.106, W.107, F.110, F.158, F.512, L.516, M.520, F.585
- Ligands: 6OU.7
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:W.107, A:W.107, A:F.110, A:F.110, A:F.158, A:F.512, A:L.516, A:F.585
- Salt bridges: A:R.106, A:R.164
6OU.10: 8 residues within 4Å:- Chain A: I.51, C.54, H.63, Y.64, I.518, T.539, F.540, P.541
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:I.51, A:Y.64, A:I.518, A:F.540
- Salt bridges: A:H.63
6OU.11: 4 residues within 4Å:- Chain A: Y.64, F.540, P.1130
- Ligands: 6OU.12
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:F.540
6OU.12: 14 residues within 4Å:- Chain A: L.517, P.541, R.542, F.544, M.545, F.548, I.1125, P.1130, G.1133, I.1134, H.1137, V.1138, F.1141
- Ligands: 6OU.11
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:L.517, A:P.541, A:F.544, A:F.544, A:F.548, A:P.1130, A:H.1137, A:V.1138, A:F.1141, A:F.1141
- Salt bridges: A:R.542
6OU.13: 6 residues within 4Å:- Chain A: S.403, Y.405, N.1100, V.1101, M.1105
- Ligands: 6OU.5
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:V.1101
- Hydrogen bonds: A:N.1100, B:Y.374, B:Y.374
6OU.14: 19 residues within 4Å:- Chain A: V.482, V.483, L.485, I.486, I.488, S.489, L.492, V.496, F.500, G.501, G.503, I.1022, L.1023, L.1024, T.1026, L.1027, L.1142, I.1146, G.1147
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:V.483, A:L.485, A:I.486, A:I.486, A:I.486, A:I.488, A:L.492, A:I.1022, A:I.1022, A:L.1023, A:L.1024, A:L.1027, A:I.1146
- Hydrogen bonds: A:G.503
6OU.15: 9 residues within 4Å:- Chain A: S.1271, R.1272, R.1273, Y.1276, L.1279, F.1312, G.1316, K.1322, L.1325
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:R.1273, A:Y.1276, A:L.1279, A:F.1312, A:F.1312
- Hydrogen bonds: A:R.1272, A:R.1273
- Salt bridges: A:R.1272, A:R.1272, A:R.1273, A:K.1322
- 2 x CLR: CHOLESTEROL(Non-covalent)
CLR.16: 5 residues within 4Å:- Chain A: P.916, I.920, Y.923, I.927, F.928
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:P.916, A:I.920, A:Y.923, A:I.927, A:I.927, A:F.928
CLR.17: 6 residues within 4Å:- Chain A: Y.415, Y.419, T.462, L.463, Y.466, P.467
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:Y.415, A:T.462, A:L.463, A:Y.466, A:P.467
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kang, Y. et al., Structure of voltage-modulated sodium-selective NALCN-FAM155A channel complex. Nat Commun (2020)
- Release Date
- 2020-11-18
- Peptides
- Sodium leak channel non-selective protein: A
Transmembrane protein FAM155A: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-1-1-mer
- Ligands
- 3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 12 x 6OU: [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate(Non-covalent)
- 2 x CLR: CHOLESTEROL(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Kang, Y. et al., Structure of voltage-modulated sodium-selective NALCN-FAM155A channel complex. Nat Commun (2020)
- Release Date
- 2020-11-18
- Peptides
- Sodium leak channel non-selective protein: A
Transmembrane protein FAM155A: B - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.